IRCT20200317046797N5
Recruiting
Phase 2
Treatment of COVID-19-induced cytokine storm with filter hemoperfusion HA330
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Tabriz University of Medical Sciences
- Enrollment
- 10
- Status
- Recruiting
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Positive PCR for COVID\-19
- •PaO2/FiO2 less than 200 mmHg
- •More than 50% involvement of pulmonary fields in CT scan
- •Respiratory rate more than 30/minute
- •Resting O2 saturation less than 90%
Exclusion Criteria
- •Coagulation abnormality
- •Plasma platelets count \<30000/µL
- •Other viral infection and bacterial sepsis
- •Advanced multi\-organ failure
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Treatment with Omega-3 polyunsaturated fatty acids in COVID-19 patients.A single-blind, randomized, placebo-controlled feasibility study.SARS-COV-2 InfectionMedDRA version: 23.0Level: LLTClassification code 10084272Term: SARS-CoV-2 infectionSystem Organ Class: 100000004862Therapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2020-002293-28-SEKarolinska University Hospital40
Completed
Not Applicable
Melatonin in COVID-19IRCT20200922048804N1Tehran University of Medical Sciences20
Not yet recruiting
Phase 2
se of Steroid inhalers in COVID.CTRI/2021/05/033817YOU BREATHE WE CARE
Recruiting
Not Applicable
Covid High-intensity Immunosuppression in Cytokine release syndromeCOVID-19 pneumoniaNL-OMON20650Zuyderland Medical Center160
Recruiting
Not Applicable
Treatment of Sars-CoV2 infections (Covid-19) with valsartan vs placebo, a three-armed randomized, partly blinded trialCovid-19DRKS00021732Klinikum St. Georg gGmbH300